How to recognize PCOS: Results of a web-based survey at IVF-worldwide.com

Ning Ning, Adam Balen, Paul R. Brezina, Milton Leong, Zeev Shoham, Edward E Wallach, Yulian Zhao

Research output: Contribution to journalArticle

Abstract

This retrospective evaluation of a web-based survey posted from 1 to 30 September 2010 was to determine which diagnostic tools physicians are currently utilizing to diagnose polycystic ovary syndrome (PCOS). Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82%), National Institutes of Health criteria (8%), Androgen Excess Society 2006 criteria (3%) and other classification systems (7%). Many providers utilized diagnostic tools not necessarily included in traditional classification systems: 58% of respondents evaluated LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-Müllerian hormone (22%) and impaired glucose tolerance (74%) in diagnosing PCOS. Many respondents (64%) felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In conclusion, while the majority of centres (82%) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future.

Original languageEnglish (US)
Pages (from-to)500-505
Number of pages6
JournalReproductive BioMedicine Online
Volume26
Issue number5
DOIs
StatePublished - 2013

Fingerprint

Polycystic Ovary Syndrome
Androgens
Anovulation
Physicians
Glucose Intolerance
Surveys and Questionnaires
National Institutes of Health (U.S.)
Prolactin
Ovary
Hormones
Serum

Keywords

  • androgen
  • diagnosis
  • impaired glucose tolerance
  • LH/FSH ratio
  • PCOS

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

How to recognize PCOS : Results of a web-based survey at IVF-worldwide.com. / Ning, Ning; Balen, Adam; Brezina, Paul R.; Leong, Milton; Shoham, Zeev; Wallach, Edward E; Zhao, Yulian.

In: Reproductive BioMedicine Online, Vol. 26, No. 5, 2013, p. 500-505.

Research output: Contribution to journalArticle

Ning, Ning ; Balen, Adam ; Brezina, Paul R. ; Leong, Milton ; Shoham, Zeev ; Wallach, Edward E ; Zhao, Yulian. / How to recognize PCOS : Results of a web-based survey at IVF-worldwide.com. In: Reproductive BioMedicine Online. 2013 ; Vol. 26, No. 5. pp. 500-505.
@article{de7fd902c7464ff49e77a2d1fa47f997,
title = "How to recognize PCOS: Results of a web-based survey at IVF-worldwide.com",
abstract = "This retrospective evaluation of a web-based survey posted from 1 to 30 September 2010 was to determine which diagnostic tools physicians are currently utilizing to diagnose polycystic ovary syndrome (PCOS). Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82{\%}), National Institutes of Health criteria (8{\%}), Androgen Excess Society 2006 criteria (3{\%}) and other classification systems (7{\%}). Many providers utilized diagnostic tools not necessarily included in traditional classification systems: 58{\%} of respondents evaluated LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-M{\"u}llerian hormone (22{\%}) and impaired glucose tolerance (74{\%}) in diagnosing PCOS. Many respondents (64{\%}) felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In conclusion, while the majority of centres (82{\%}) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future.",
keywords = "androgen, diagnosis, impaired glucose tolerance, LH/FSH ratio, PCOS",
author = "Ning Ning and Adam Balen and Brezina, {Paul R.} and Milton Leong and Zeev Shoham and Wallach, {Edward E} and Yulian Zhao",
year = "2013",
doi = "10.1016/j.rbmo.2013.01.009",
language = "English (US)",
volume = "26",
pages = "500--505",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - How to recognize PCOS

T2 - Results of a web-based survey at IVF-worldwide.com

AU - Ning, Ning

AU - Balen, Adam

AU - Brezina, Paul R.

AU - Leong, Milton

AU - Shoham, Zeev

AU - Wallach, Edward E

AU - Zhao, Yulian

PY - 2013

Y1 - 2013

N2 - This retrospective evaluation of a web-based survey posted from 1 to 30 September 2010 was to determine which diagnostic tools physicians are currently utilizing to diagnose polycystic ovary syndrome (PCOS). Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82%), National Institutes of Health criteria (8%), Androgen Excess Society 2006 criteria (3%) and other classification systems (7%). Many providers utilized diagnostic tools not necessarily included in traditional classification systems: 58% of respondents evaluated LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-Müllerian hormone (22%) and impaired glucose tolerance (74%) in diagnosing PCOS. Many respondents (64%) felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In conclusion, while the majority of centres (82%) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future.

AB - This retrospective evaluation of a web-based survey posted from 1 to 30 September 2010 was to determine which diagnostic tools physicians are currently utilizing to diagnose polycystic ovary syndrome (PCOS). Responses from 262 IVF centres in 68 countries are included in the study. Providers used various diagnostic criteria to diagnose PCOS, including the Rotterdam criteria (82%), National Institutes of Health criteria (8%), Androgen Excess Society 2006 criteria (3%) and other classification systems (7%). Many providers utilized diagnostic tools not necessarily included in traditional classification systems: 58% of respondents evaluated LH/FSH ratio in addition to androgen concentrations to define patients with PCOS; physicians also commonly obtain measurement of anti-Müllerian hormone (22%) and impaired glucose tolerance (74%) in diagnosing PCOS. Many respondents (64%) felt that polycystic-appearing ovaries on ultrasound with anovulation and a normal serum prolactin should be adequate criteria to diagnose PCOS. In conclusion, while the majority of centres (82%) uses the Rotterdam criteria to diagnose PCOS, other criteria and diagnostic tools are commonly used in evaluating patients with suspected PCOS. This study highlights the need for continual re-evaluation of PCOS diagnostic criteria with an ultimate goal of developing a consensus definition for the disorder in the future.

KW - androgen

KW - diagnosis

KW - impaired glucose tolerance

KW - LH/FSH ratio

KW - PCOS

UR - http://www.scopus.com/inward/record.url?scp=84877073175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877073175&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2013.01.009

DO - 10.1016/j.rbmo.2013.01.009

M3 - Article

C2 - 23419796

AN - SCOPUS:84877073175

VL - 26

SP - 500

EP - 505

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 5

ER -